Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
University of Washington